Designing Ground-Breaking Therapies

Bringing hope to patients with demyelinating diseases

Finding hope by expanding the frontiers of therapy

We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with demyelinating diseases

Innovative chemistry to design modulators of key membrane receptors

Development and discovery programs to treat demyelinating diseases

Multidisciplinary team in drug development and world-class key opinion leaders

With Phase I completed, Find is advancing tasronetide toward the next clinical milestone.

Published in the open-access journal Biomedicine & Pharmacotherapy, this article highlights the dual mechanism of…

We’re pleased to welcome Dr. Nancy Messier and Dr. Thierry Abribat to our Board of…

... share our passion for discovering and developing breakthrough science to bring hope to people’s lives